SCHEMBL6289019

SCHEMBL6289019

CN1C(=O)C(Cc2ccc(F)c(F)c2)C(=O)C2=C1CC(C(=O)O)=C2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
HSD17B10 Q99714 2/20 0.35
GAA P10253 1/20 0.35
CNR1 P21554 3/20 0.33
CCR5 P51681 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CNR2 P34972 1/20 0.33
PTGS1 P23219 2/20 0.32
PTGS2 P35354 2/20 0.32
SIGMAR1 Q99720 2/20 0.31
MAPT P10636 1/20 0.31
KDM4C Q9H3R0 1/20 0.31
TBXA2R P21731 1/20 0.31
PTGER4 P35408 1/20 0.31
PTGER3 P43115 1/20 0.31
PTGER2 P43116 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288744 0.78 KDM4C (0.34) ALDH1A1HSD17B10GAACNR1CNR2
SCHEMBL6488442 0.76 ALDH1A1 (0.34) ALDH1A1CNR1TSHRL3MBTL1CNR2
SCHEMBL6292698 0.74 ALDH1A1 (0.35) ALDH1A1HSD17B10GAACNR1CCR5
SCHEMBL6288960 0.72 ALDH1A1 (0.38) ALDH1A1HSD17B10GAACNR1TSHR
SCHEMBL6680077 0.72 NR1H2 (0.40) ALDH1A1KDM4CTBXA2RPTGER4PTGER3
SCHEMBL6292143 0.72 ALDH1A1 (0.34) ALDH1A1HSD17B10GAACNR1TSHR
SCHEMBL8344071 0.70 MAOB (0.34) ALDH1A1HSD17B10GAACNR1TSHR
SCHEMBL6289353 0.70 DAO (0.34) ALDH1A1HSD17B10GAACNR1CCR5
SCHEMBL6289343 0.70 ALDH1A1 (0.34) ALDH1A1HSD17B10GAACNR1TSHR
SCHEMBL8344055 0.68 ALDH1A1 (0.34) ALDH1A1HSD17B10GAACNR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949651-B2 Fused bicyclic metalloproteinase inhibitors WARNER-LAMBERT COMPANY (US) 2005-09-27 US disclosed
US-20040034054-A1 Fused bicyclic metalloproteinase inhibitors LINCOLN FOODSERVICE PRODUCTS INC. 2004-02-19 US disclosed
WO-2004014375-A2 FUSED BICYCLIC METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034054-A1 Fused bicyclic metalloproteinase inhibitors MMP9, MMP1, MMP2 ALDH1A1 337/4885HSD17B10 637/4885GAA 620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.